Tampa (1)

Merkel Cell Carcinoma (1)

Neuroendocrine Carcinoma of the Skin (1)

Trabecular Carcinoma of the Skin (1)

Recruiting (1)

phase 2 (1)

H. Lee Moffitt Cancer Center and Research Institute (1)

Merck Sharp & Dohme LLC (1)

lenvatinib oral product (1)

pembrolizumab (1)

drug (1)

Other (1)

Interventional (1)

trabecular carcinoma of the skin

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Dec 30, 2022